Neurophotonics Market

Neurophotonics, a peer-reviewed quarterly scientific journal, focuses on the use of optical technology in neuroscience research. In the field of biomedicine, optical technologies are becoming more prominent to diagnose and treat various medical conditions. Light-based technologies are also becoming more popular in neurology due to their advantages over other methods (such as radio waves, magnetic fields, and X-rays), as well as features like lower prices, portability, and long-term safety. Neurophotonic technology is currently used in three areas: diagnosis, therapy, and research. In research and diagnosis, imaging tools are often used. Biomodulation and neurostimulation are the most commonly used forms of therapeutic systems.

Request a sample to get more information on the Neurophotonics market (Use Corporate email ID to Get Higher Priority):

Detail Segmentation
Segmentation of the global market for neurophotonics is based on – System Types and Applications, End-Users, and Region. Below is a detailed segmental description.

Based on System Types:
• Microscopy
• Spectroscopy
• Multimodal
• Other System Types

Based on Applications:
• Research
• Diagnostics
• Therapeutics

Based on End-Users:
• Hospitals
• Clinics
• Other End-Users

Based on Region:
• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

Market Dynamics –

The Global Neurophotonics Market Drivers:
This market is being driven by significant investment in research and development activities. In 2014, the United Nations launched Brain Research Through Advancing Innovative Neurotechnologies Initiative (BRAIN). This initiative aims to understand the inner workings of human minds. The National Institutes of Health has also contributed several investments. This market is expected to benefit from government measures like these. The market for neurophotonics has also been bolstered by the increase in neurological diseases, especially those that are age-related or developmental, and an increase in the geriatric population. These are some of the factors that will increase this market over the next few years.

Global Neurophotonics Market Opportunity:
This market will be able to take advantage of technological advances and improvements in healthcare devices. Neurophotonics has the potential to be a major player in areas such as the detection of pain. The US Department of Health and Human Services found that 18% of respondents to their survey said they have visited a healthcare provider for lower back pain in the past year. However, this is only possible if there are several studies. It will open up a lot of opportunities for expansion if it succeeds.

Global Neurophotonics Market Restraints:
This market may be affected by the rising cost of R&D, the rise in the prices of treatments, and the lack of awareness about advanced technologies.

Competitive Landscape –
The market’s key players are: Hitachi Ltd., Artinis Medical Systems BV, Cairn Research, Femtonics Ltd., and Carl Zeiss AG, among others.

The Key Developments
The year 2019
Hitachi Ltd., Jichi Medical University JMU, International University Health and Welfare (IUHW), and Chuo University Chuo-U created a device in February 2019 to help in the early detection of concurrent Autism Spectrum Disorders (ASD) in patients suffering from Attention Deficit Hyperactivity Disorder.
Researchers from the University of Strathclyde’s Institute of Photonics combined a 10×10 array of microneedles made of glass with a micro-LED array in September 2019. This can be placed near the brain’s surface. LED-lit microneedles transmit light to 181 spots (1.5mm depth), which can optogenetically stimulate hundreds.